27EC Tuluc, Madalina - Thomas Jefferson University - Thomas Jefferson University
mxt028

Madalina Tuluc, MD, PhD

Contact Dr. Tuluc

132 South 10th Street
285R Main
Philadelphia, PA 19107

(215) 955-7524
(215) 923-1969 fax

Most Recent Peer-reviewed Publications

  1. Ciliated Adenosquamous Carcinoma: Expanding the Phenotypic Diversity of Human Papillomavirus-Associated Tumors
  2. Aging effects on pedicled fasciocutaneous flap survival in rats
  3. Malignant Sarcomatous Transformation of Fibrous Dysplasia
  4. A Rare Case of Carcinoma Cuniculatum Involving the Larynx in Association with a Saccular Cyst
  5. Parathyroid Hormone-Related Peptide-Linked Hypercalcemia in a Melanoma Patient Treated with Ipilimumab: Hormone Source and Clinical and Metabolic Correlates
  6. Orbital involvement by NUt midline carcinoma
  7. Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis
  8. Multicompartment metabolism in papillary thyroid cancer
  9. Mitochondrial Metabolism as a Treatment Target in Anaplastic Thyroid Cancer
  10. Salivary duct carcinoma: The predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expression
  11. Malignant Sarcomatous Transformation of Fibrous Dysplasia
  12. Thyroid Cytology
  13. Recurrent epistaxis and nasal congestion
  14. False-positive fna due to highly sensitive braf assay
  15. Tumor microenvironment in head and neck squamous cell carcinoma
  16. Chondrosarcoma of the hyoid bone: Case report and review of current management options
  17. Current management of locally advanced head and neck cancer: The combination of chemotherapy with locoregional treatments
  18. Combination of p16 levels and pre-radiotherapy factors predicts outcome in patients treated for oropharyngeal carcinoma
  19. Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients
  20. Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment RAS and NFκB target stromal MCT4
0